TAKEDA ANNOUNCES LAUNCH OF EXCHANGE OFFER
(WorldNews Japan)

Osaka, Japan, November 14, 2019 --- Takeda Pharmaceutical Company Limited (`Takeda`) (TSE:4502/NYSE:TAK) today announces that, based on its determination as of November 12, 2019, it has launched an offer to exchange new registered notes for any and all of the outstanding unregistered notes that it issued on November 19, 2018 in a private placement pursuant to Rule 144A and Regulation S under the U.S. Securities Act of 1933, as amended (the `Securities Act`). Takeda is offering to exchange (the `Exchange Offer`) its $1.250 billion aggregate principal amount of its newly issued 4.000% Senior Notes due 2021, $1.500 billion aggregate principal amount of its newly issued 4.400% Senior Notes due...